Earn up to 2 CME/CE credits

FOCUS ON PSYCHOTIC AND MOOD DISORDERS

TUESDAY, NOVEMBER 12, 2024 | 7:00 pm — 10:00 pm ET

We are pleased to invite you to the Psychiatry Update: Focus on Psychotic and Mood Disorders, a virtual CME meeting with renowned faculty and informative presentations on schizophrenia, MDD, and bipolar disorder, as well as innovative treatments and how to implement them into practice.

Our interactive conference center makes participating in the live virtual sessions and Q&As easy. We know that connecting with colleagues is crucial; our forums make it seamless to network, share ideas, and catch up with colleagues around the world.

All of this is in service of what matters most – taking home the kind of breakthroughs that can make a difference in your patients’ lives. This is a one-of-a-kind experience for the psychiatry community that you won’t want to miss - a taste of our annual Psychiatry Update, which returns in March 2025!

Agenda Highlights:

Presentation and discussion of challenging cases in prurigo nodularis, hidradenitis suppurativa, psoriasis, and atopic dermatitis
Exploration of diagnostic and therapeutic considerations in patients with skin of color
Interactive Q&A with expert faculty

NON-CME/CE BONUS PRESENTATION

7:00 pm — 8:00 pm

A Clear Choice for Plaque Psoriasis Topical Treatment

This is a Non-CME/CE Presentation

Mona Shahriari, MD, FAAD

Learn about a once-daily, topical treatment without steroids! We’ll explore the clinical safety and efficacy data and how this treatment could fit into your practice.

SPEAKER

Mona Shahriari, MD, FAAD

AGENDA

7:00 pm — 8:00 pm

Psychotic Disorders

7:00 - 7:05 | Introduction

Christoph U. Correll, MD

7:05 - 7:20 | Schizophrenia: Pathophysiology and Current Treatment Regimen Into Practice

Diana O. Perkins, MD, MPH

7:20 - 7:45 | Schizophrenia: Novel Treatments and How to Implement Them in Practice

Christoph U. Correll, MD

7:45 - 8:00 | Audience Q&A and Panel Discussion

Diana O. Perkins, MD, MPH; Christoph U. Correll, MD

8:00 pm — 9:00 pm

Non-CME/CE Bonus Presentation

An Established Treatment Option for Managing Bipolar I Disorder or Schizophrenia

Speaker: Leslie Citrome, MD, MPH

FACULTY

Leslie Citrome, MD, MPH

Christoph U. Correll, MD

Joseph F. Goldberg, MD

Diana O. Perkins, MD, MPH

REGISTRATION

Standard Rate: $50

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

TARGET AUDIENCE

This conference is designed for psychiatrists, neurologists, primary care physicians, nurse practitioners, nurses, physician assistants, pharmacists, and other healthcare professionals who provide care to patients with psychiatric conditions.

LEARNING OBJECTIVES

As a result of participating in this live activity, participants should be able to:

Describe innovations in pharmacotherapy for the treatment of schizophrenia.
Demonstrate competence in their ability to identify and diagnose mood disorders.

JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 2.0 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on certificates.

Continuing Pharmacy Education

PIM designates this continuing education activity for 2.0 contact hours (.XXX CEUs) of the Accreditation Council for Pharmacy Education.

Continuing Physician Assistants Education

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.75 Category 1 credits for completing this activity.

Interprofessional Continuing Education

This activity was planned by and for the healthcare team, and learners will receive 2.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

Credit amount subject to change

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. The existence or absence of COI for everyone in a position to control educational content will be disclosed to participants prior to the start of each activity.